查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1905391

日本生物样本库市场报告（按样本类型、生物样本库类型、应用、最终用户和地区划分，2026-2034年）

Japan Biobanking Market Report by Specimen Type, Biobank Type, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本生物样本库市场规模达39.703亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到57.397亿美元，2026年至2034年间的复合年增长率（CAGR）为4.18%。对个人化医疗日益增长的需求，以及为支持研究和开发客製化疗法而对生物样本和资料的需求不断增长，是推动市场成长的主要因素。

本报告解答的关键问题：

  • 日本生物样本库市场目前的表现如何？未来几年又将如何发展？
  • 新冠疫情对日本生物样本库市场产生了哪些影响？
  • 日本生物样本库市场依样本类型分類的组成是怎样的？
  • 日本生物样本库市场依生物样本库类型分類的组成是怎样的？
  • 日本生物样本库市场依应用领域分類的组成是怎样的？
  • 日本生物样本库市场依最终使用者分類的组成是怎样的？
  • 日本生物样本库市场价值链的各个阶段有哪些？
  • 日本生物样本库的关键驱动因素和挑战是什么？
  • 日本生物样本库市场的结构是怎么样的？主要参与者有哪些？
  • 日本生物样本库市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本生物样本库市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本生物样本库市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本生物样本库市场－依样本类型划分

  • 血液製品
  • 实体组织
  • 细胞系
  • 核酸
  • 其他的

第七章：日本生物样本库市场－依生物样本库类型划分

  • 基于人群的生物样本库
  • 以疾病为导向的生物样本库

第八章：日本生物样本库市场－依应用领域划分

  • 疗法
  • 研究

第九章：日本生物样本库市场－以最终用户划分

  • 学术机构
  • 製药和生物技术公司

第十章：日本生物样本库市场－按地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本生物样本库市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十二章：关键参与者简介

第十三章：日本生物样本库市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章：附录

简介目录
Product Code: SR112026A18685

Japan biobanking market size reached USD 3,970.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 5,739.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.18% during 2026-2034. The increasing demand for personalized medicine, coupled with the growing need for biological samples and data to support research and the development of tailored treatments, is driving the market.

Biobanking is a crucial aspect of modern healthcare and scientific research. It involves the systematic collection, storage, and management of biological samples, such as blood, tissue, and DNA, from individuals for future use in research, diagnostics, and treatment development. Biobanks play a vital role in advancing our understanding of diseases, genetics, and personalized medicine. These repositories preserve specimens and their associated data under strict ethical and regulatory guidelines, ensuring patient privacy and informed consent. Biobanked samples serve as valuable resources for studying diseases, identifying biomarkers, and testing new therapies. They facilitate large-scale, longitudinal studies that can uncover patterns and trends in health and disease over time. Biobanking promotes collaboration among researchers, accelerates medical discoveries, and enhances the potential for tailored treatments based on an individual's genetic makeup. It also supports translational research, bridging the gap between laboratory findings and clinical applications. In summary, biobanking is a critical infrastructure in modern healthcare, advancing medical knowledge and improving patient care.

Japan Biobanking Market Trends:

The biobanking market in Japan is experiencing robust growth due to several key drivers. Firstly, advancements in medical research and the increasing focus on personalized medicine have propelled the demand for biobanking services. These repositories of biological samples enable researchers to access a diverse range of specimens, accelerating their efforts in understanding diseases and developing targeted therapies. Moreover, the growing awareness of the importance of preserving biological materials for future research has prompted both public and private sector investments in biobanking infrastructure. In addition to this, the rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, necessitates extensive biobanking to support the discovery of biomarkers and therapeutic targets. The adoption of genomic medicine and the integration of genetic information into healthcare practices have further amplified the demand for biobanking solutions. Lastly, regulatory initiatives and ethical considerations have strengthened the framework surrounding biobanking, instilling confidence among stakeholders and encouraging their participation. These interconnected drivers are propelling the biobanking market in Japan towards unprecedented growth, promising a future of improved healthcare outcomes and medical breakthroughs.

Japan Biobanking Market Segmentation:

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

Application Insights:

  • Therapeutics
  • Research

End User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan biobanking market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan biobanking market?
  • What is the breakup of the Japan biobanking market on the basis of specimen type?
  • What is the breakup of the Japan biobanking market on the basis of biobank type?
  • What is the breakup of the Japan biobanking market on the basis of application?
  • What is the breakup of the Japan biobanking market on the basis of end user?
  • What are the various stages in the value chain of the Japan biobanking market?
  • What are the key driving factors and challenges in the Japan biobanking?
  • What is the structure of the Japan biobanking market and who are the key players?
  • What is the degree of competition in the Japan biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biobanking Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Biobanking Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Biobanking Market - Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Solid Tissue
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Cell Lines
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Nucleic Acid
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Biobanking Market - Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)

8 Japan Biobanking Market - Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Research
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Biobanking Market - Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Biobanking Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Specimen Type
    • 10.1.4 Market Breakup by Biobank Type
    • 10.1.5 Market Breakup by Application
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Specimen Type
    • 10.2.4 Market Breakup by Biobank Type
    • 10.2.5 Market Breakup by Application
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Specimen Type
    • 10.3.4 Market Breakup by Biobank Type
    • 10.3.5 Market Breakup by Application
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Specimen Type
    • 10.4.4 Market Breakup by Biobank Type
    • 10.4.5 Market Breakup by Application
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Specimen Type
    • 10.5.4 Market Breakup by Biobank Type
    • 10.5.5 Market Breakup by Application
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Specimen Type
    • 10.6.4 Market Breakup by Biobank Type
    • 10.6.5 Market Breakup by Application
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Specimen Type
    • 10.7.4 Market Breakup by Biobank Type
    • 10.7.5 Market Breakup by Application
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Specimen Type
    • 10.8.4 Market Breakup by Biobank Type
    • 10.8.5 Market Breakup by Application
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Biobanking Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Biobanking Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix